PR Newswire
SAN DIEGO
,
Nov. 19, 2021
/PRNewswire/ — Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that Chief Executive Officer
Saundra Pelletier
will participate in a fireside chat and host one-on-one meetings at the Piper Sandler 33
rd
Annual Virtual Healthcare Conference being held from
November 29
–
December 2, 2021
.
The Company’s pre-recorded fireside chat will be available for on demand listening beginning at
10:00am ET
(
7:00am PT
) on
Monday, November 22, 2021
for 90 days through the Piper Sandler conference site and at
https://evofem.investorroom.com/Piper2021
.
To request a one-on-one meeting with Evofem during the conference, please contact your Piper Sandler representative.
About Evofem Biosciences
Evofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products to address unmet needs in women’s sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (chlamydia and gonorrhea). The Company’s first FDA-approved product, Phexxi® (lactic acid, citric acid and potassium bitartrate), is a hormone-free, on-demand prescription contraceptive vaginal gel. It comes in a box of 12 pre-filled applicators and is applied 0-60 minutes before each act of sex. Learn more at phexxi.com and
evofem.com
.
Phexxi
®
is a registered trademark of Evofem Biosciences, Inc.
Investor Relations Contact
Amy Raskopf
Evofem Biosciences, Inc.
[email protected]
Mobile: (917) 673-5775
View original content to download multimedia:
https://www.prnewswire.com/news-releases/evofem-biosciences-to-participate-in-piper-sandler-33rd-annual-healthcare-conference-301428861.html
SOURCE Evofem Biosciences, Inc.
